Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMND
CMND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMND News
Clearmind's Positive Clinical Trial Results May Support Breakthrough Therapy Designation
Apr 27 2026
Newsfilter
CLEARMIND MEDICINE INC - HAS NOT APPLIED FOR OR BEEN GRANTED FDA BREAKTHROUGH THERAPY DESIGNATION FOR MEAI
Apr 27 2026
moomoo
Clearmind Medicine Reports Positive Clinical Trial Results and Regulatory Support
Apr 21 2026
NASDAQ.COM
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
stocktwits
Clearmind's Drug Clinical Trial Achieves Success
Apr 20 2026
Newsfilter
Trump Administration to Examine Safety of Psychedelic Drug for PTSD
Apr 18 2026
Yahoo Finance
Trump Administration to Examine Ibogaine Research for PTSD Funding
Apr 16 2026
stocktwits
Clearmind Medicine's CMND-100 Trial Receives Positive DSMB Recommendation
Apr 16 2026
NASDAQ.COM
Clearmind Receives Positive Recommendation for CMND-100 Trial
Apr 15 2026
Newsfilter
Clearmind's Drug Trial Achieves Primary Endpoint
Apr 14 2026
Newsfilter
Clearmind Medicine Reports Positive Progress in AUD Drug Trial
Mar 31 2026
NASDAQ.COM
Clearmind Advances Clinical Trial for Alcohol Use Disorder
Mar 30 2026
Newsfilter
Clearmind Files Patent Application in India for Next-Gen Psychedelic Compounds
Mar 27 2026
Newsfilter
Clearmind Unveils Patent for Innovative Weight Loss Therapy
Mar 10 2026
Yahoo Finance
Clearmind's CMND-100 Clinical Trial Receives Approval
Mar 04 2026
Newsfilter
Clearmind's MEAI Drug Breakthrough in Obesity Treatment
Feb 19 2026
PRnewswire
Show More News
